Retina Consultants of Southern Colorado PC — Colorado Springs, Colorado

Retina Consultants of Southern Colorado PC is a clinical research site located in Colorado Springs, Colorado, United States 80909.

Crixeo Clinical Trials Trust Score: 18/100 (FAILING). This profile has not yet been claimed by the site owner.

Retina Consultants of Southern Colorado PC has participated in 13 clinical trials with 1 currently active.

Therapeutic areas: Neovascular Age-Related Macular Degeneration, Diabetic Retinopathy, Macular Edema.

Sponsors: Bayer, Hoffmann-La Roche, Genentech, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Colorado Springs

Browse all research sites in Colorado · View every site in Colorado Springs

Sponsor Feasibility Report

Trust Score: 18/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Retina Consultants of Southern Colorado PC?

Retina Consultants of Southern Colorado PC has a Crixeo Trust Score of 18/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Retina Consultants of Southern Colorado PC conducted?

Retina Consultants of Southern Colorado PC has 13 clinical trials on record, with 1 currently active. Their work covers Neovascular Age-Related Macular Degeneration, Diabetic Retinopathy, Macular Edema.

Is Retina Consultants of Southern Colorado PC accredited by Crixeo Clinical Trials?

Retina Consultants of Southern Colorado PC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Retina Consultants of Southern Colorado PC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.